HILLSTREAM BIOPHARMA INC (HILS)
US4327051011 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.97M | 6.88M | 3.21M | 1.81M | 1.42M | |||
| Research and Development | 3.59M | 2.28M | 1.84M | 847.27K | 368.73K | |||
| Selling, General, and Administrative Expenses | 5.38M | 4.60M | 1.37M | 671.88K | 625.81K | |||
| Operating Income | -8.97M | -6.88M | -3.21M | -1.81M | -1.42M | |||
| Interest Income/Expense | 53.79K | -1.59M | -831.28K | -246.53K | -75.07K | |||
| Other Income/Expense | N/A | 0.00 | 1.83M | -362.49K | -26.46K | |||
| Non Recurring Items | N/A | N/A | N/A | -290.00K | -430.00K | |||
| Income Before Taxes | -8.92M | -8.47M | -2.21M | -2.42M | -1.53M | |||
| Net Income | -8.92M | -8.47M | -2.21M | -2.42M | -1.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.73 | -0.75 | -0.19 | -0.24 | -0.15 | |||
| Statistics | ||||||||
All data in USD